Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001181431-11-016796)

Filing Details

Accession Number:
0001181431-11-016796
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-09 12:00:00
Reporting Period:
2011-03-07
Filing Date:
2011-03-09
Accepted Time:
2011-03-09 16:13:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333763 Chelsea Therapeutics International Ltd. CHTP Biological Products, (No Disgnostic Substances) (2836) 203174202
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1403961 D William Schwieterman 3530 Toringdon Way
Suite 200
Charlotte NC 28277		 Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-07 40,000 $3.96 85,451 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Show Other Fields >>
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $7.72 2021-01-11 50,000 50,000 Direct
Common Stock Stock Option (Right to Buy) $2.96 2020-01-19 10,000 10,000 Direct
Common Stock Stock Option (Right to Buy) $2.82 2019-10-29 75,000 75,000 Direct
Common Stock Stock Option (Right to Buy) $1.78 2019-01-22 30,000 30,000 Direct
Common Stock Stock Option (Right to Buy) $5.07 2018-06-26 35,000 35,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-01-11 50,000 50,000 Direct
2020-01-19 10,000 10,000 Direct
2019-10-29 75,000 75,000 Direct
2019-01-22 30,000 30,000 Direct
2018-06-26 35,000 35,000 Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $4.02 to $3.92. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  2. Option vests in four equal annual installments beginning on January 11, 2012.
  3. Option vests in four equal annual installments beginning on January 19, 2011.
  4. Option vests in four equal annual installments beginning on October 29, 2010.
  5. Option vests in four equal annual installments beginning on January 22, 2010.
  6. Option vests in four equal annual installments beginning on June 26, 2009.